212
Participants
Start Date
December 18, 2012
Primary Completion Date
January 27, 2016
Study Completion Date
October 31, 2022
Selumetinib 75 mg
Three selumetinib capsules (Hyd-Sulfate) 25 mg will be administered orally, twice daily, (75 mg dose bd) on an uninterrupted schedule.
Docetaxel 75 mg/m2
Docetaxel 75 mg/m2 will be administered intravenously on day 1 of each 21 day cycle.
Docetaxel 60 mg/m2
Docetaxel 60 mg/m2 will be administered intravenously on day 1 of each 21 day cycle.
Placebo
Three placebo capsules will be administered orally uninterrupted twice daily.
Research Site, Budapest
Research Site, Budapest
Research Site, Budapest
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Törökbálint
Research Site, Vratsa
Research Site, Miskolc
Research Site, Edelény
Research Site, Plovdiv
Research Site, Plovdiv
Research Site, Nyíregyháza
Research Site, Kaposvár
Research Site, Székesfehérvár
Research Site, Varna
Research Site, Győr
Research Site, New York
Research Site, New York
Research Site, Mineola
Research Site, Philadelphia
Research Site, Großhansdorf
Research Site, Brest
Research Site, Atlanta
Research Site, Hollywood
Research Site, Nashville
Research Site, Essen
Research Site, Moers
Research Site, Lille
Research Site, Chicago
Research Site, Clermont-Ferrand
Research Site, Wiesbaden
Research Site, Pierre-Bénite
Research Site, Marrero
Research Site, Esslingen am Neckar
Research Site, Löwenstein
Research Site, Karlsruhe
Research Site, Aurora
Research Site, Santa Monica
Research Site, Villejuif
Research Site, Würzburg
Research Site, Boston
Research Site, Hershey
Research Site, Barretos
Research Site, Brasília
Research Site, Ijuí
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Santo André
Research Site, São José do Rio Preto
Research Site, São Paulo
Research Site, São Paulo
Research Site, São Paulo
Research Site, Caen
Research Site, 's-Hertogenbosch
Research Site, Amsterdam
Research Site, Amsterdam
Research Site, Bergen op Zoom
Research Site, Maastricht
Research Site, Gdansk
Research Site, Grudziądz
Research Site, Krakow
Research Site, Olsztyn
Research Site, Poznan
Research Site, Sucha Beskidzka
Research Site, Szczecin
Lead Sponsor
AstraZeneca
INDUSTRY